Sensei Bio stock skyrockets on acquisition and $200m financing Sensei stock surges after acquiring Faeth Therapeutics and securing $200 million private placement to advance cancer pipeline.

Sensei Biotherapeutics stock skyrockets 206% after acquiring Faeth Therapeutics and securing $200M private placement. The deal advances PIKTOR, a promising PI3K/mTOR inhibitor for endometrial and breast cancer.
#News #SenseiBio #Biotech #CancerResearch #StockNews #PIKTOR

Sensei Bio stock skyrockets on acquisition and $200m financing Sensei stock surges after acquiring Faeth Therapeutics and securing $200 million private placement to advance cancer pipeline.

Sensei Biotherapeutics stock skyrockets 206% after acquiring Faeth Therapeutics and securing $200M private placement. The deal advances PIKTOR, a promising PI3K/mTOR inhibitor for endometrial and breast cancer.
#News #SenseiBio #Biotech #CancerResearch #StockNews #PIKTOR